Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors

Cancer Research

Volumn 64, Issue 23, 2004, Pages 8585-8594

  Wang, Weigang ^a   Goswami, Sumanta ^a   Lapidus, Kyle ^a   Wells, Amber L ^a   Wyckoff, Jeffrey B ^a   Sahai, Erik ^a   Singer, Robert H ^a   Segall, Jeffrey E ^a   Condeelis, John S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN RELATED PROTEIN 2; ACTIN RELATED PROTEIN 3; ALPHA TUBULIN; ANNEXIN; BETA ACTIN; BETA CATENIN; BETA1 INTEGRIN; CELL PROTEIN; CHAPERONIN; COFILIN; COLLAGEN TYPE 3; CRIPT PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; G PROTEIN COUPLED RECEPTOR; KINESIN; KINETIN; LIM PROTEIN; LIPOCORTIN 5; MOESIN; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PROTEIN CDC42; PROTEIN KINASE C; PROTEIN ZBP1; RAS PROTEIN; RHO FACTOR; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; TROPOMYOSIN; UNCLASSIFIED DRUG; VINCULIN; ZYXIN;

ACTIN POLYMERIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CELL DIVISION; CELL SURVIVAL; CHEMOTAXIS; CONTROLLED STUDY; DNA MICROARRAY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; INVASIVE CARCINOMA; METASTASIS INHIBITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ACTINS; ANIMALS; CELL MOVEMENT; CHEMOTAXIS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GREEN FLUORESCENT PROTEINS; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM INVASIVENESS; RATS; RATS, INBRED F344; RNA, MESSENGER; RNA-BINDING PROTEINS; UP-REGULATION;

EID: 9244222742     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1136     Document Type: Article

References (59)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature (Lond) 2001;411:375-9.
3. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science (Wash DC) 1977;197:893-5.
4. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003;33:49-54.
5. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
6. Bonner RF, Emmert-Buck M, Cole K, et al. Laser capture microdissection: molecular analysis of tissue. Science (Wash DC) 1997;278:1481,1483.
7. Clark EA, Golub TR, Lander ES, Hynes RO. Genomic analysis of metastasis reveals an essential role for RhoC. Nature (Lond) 2000;406:532-5.
8. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-49.
9. Ree AH, Engebraaten O, Hovig E, Fodstad O. Differential display analysis of breast carcinoma cells enriched by immunomagnetic target cell selection: gene expression profiles in bone marrow target cells. Int J Cancer 2002;97:28-33.
10. Wyckoff JB, Jones JG, Condeelis JS, Segall JE. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res 2000;60:2504-11.
11. Wyckoff JB, Segall JE, Condeelis JS. The collection of the motile population of cells from a living tumor. Cancer Res 2000;60:5401-4.
12. Lin EY, Gouon-Evans V, Nguyen AV, Pollard JW. The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 2002;7:147-62.
13. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-40.
14. Wang W, Wyckoff JB, Wang Y, Bottinger EP, Segall JE, Condeelis JS. Gene expression analysis on small numbers of invasive cells collected by chemotaxis from primary mammary tumors of the mouse. BMC Biotechnol 2003;3:13.
15. Zhu YY, Machleder EM, Chenchik A, Li R, Siebert PD. Reverse transcriptase template switching: a SMART approach for full-length cDNA library construction. Biotechniques 2001;30:892-7.
16. Farina KL, Wyckoff JB, Rivera J, et al. Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. Cancer Res 1998;58:2528-32.
17. Wang W, Wyckoff JB, Frohlich VC, et al. Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res 2002;62:6278-88.
18. Goswami S, Sheets NL, Zavadil J, et al. Spectrum and range of oxidative stress responses of human lens epithelial cells to H2O2 insult. Invest Ophthalmol Vis Sci 2003;44:2084-93.
19. Novoradovskaya N, Whitfield ML, Basehore LS, et al. Universal Reference RNA as a standard for microarray experiments. BMC Genomics 2004;5:20.
20. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-21.
21. Farina KL, Huttelmaier S, Musunuru K, Darnell R, Singer RH. Two ZBP1 KH domains facilitate beta-actin mRNA localization, granule formation, and cytoskeletal attachment. J Cell Biol 2003;160:77-87.
22. Dal Canto RA, Shaw MK, Nolan GP, Steinman L, Fathman CG. Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis. Clin Immunol 1999;90:10-4.
23. Shestakova EA, Wyckoff J, Jones J, Singer RH, Condeelis J. Correlation of beta-actin messenger RNA localization with metastatic potential in rat adenocarcinoma cell lines. Cancer Res 1999;59:1202-5.
24. Segall JE, Tyerech S, Boselli L, et al. EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism. Clin Exp Metastasis 1996;14:61-72.
25. Nicholson RI, Gee JM, Harper ME. EGFR and cancer prognosis. Eur J Cancer 2001;37 Suppl 4:S9-15.
26. O'Sullivan C, Lewis CE, Harris AL, McGee JO. Secretion of epidermal growth factor by macrophages associated with breast carcinoma. Lancet 1993;342:148-9.
27. LeBedis C, Chen K, Fallavollita L, Boutros T, Brodt P. Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int J Cancer 2002;100:2-8.
28. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer 2003;3:921-30.
29. Mariadason JM, Arango D, Corner GA, et al. A gene expression profile that defines colon cell maturation in vitro. Cancer Res 2002;62:4791-804.
30. Bravo SB, Pampin S, Cameselle-Teijeiro J, et al. TGF-beta-induced apoptosis in human thyrocytes is mediated by p27kip1 reduction and is overridden in neoplastic thyrocytes by NF-kappaB activation. Oncogene 2003;22:7819-30.
31. Goswami S, Wang W, Wyckoff JB, Condeelis JS. Breast cancer cells isolated by chemotaxis from primary tumors show increased survival and resistance to chemotherapy. Cancer Res In press 2004.
32. Bailly M, Condeelis J. Cell motility: insights from the backstage. Nat Cell Biol 2002;4:E292-4.
33. Mogilner A, Edelstein-Keshet L. Regulation of actin dynamics in rapidly moving cells: a quantitative analysis. Biophys J 2002;83:1237-58.
34. Loisel TP, Boujemaa R, Pantaloni D, Carlier MF. Reconstitution of actin-based motility of Listeria and Shigella using pure proteins. Nature (Lond) 1999;401:613-6.
35. Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S, Mizuno K. Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem 2000;275:3577-82.
36. Edwards DC, Sanders LC, Bokoch GM, Gill GN. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1999;1:253-9.
37. Cooper JA, Schafer DA. Control of actin assembly and disassembly at filament ends. Curr Opin Cell Biol 2000;12:97-103.
38. Bear JE, Svitkina TM, Krause M, et al. Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell 2002;109:509-21.
39. Shestakova EA, Singer RH, Condeelis J. The physiological significance of beta-actin mRNA localization in determining cell polarity and directional motility. Proc Natl Acad Sci USA 2001;98:7045-50.
40. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature (Lond) 2001;411:342-8.
41. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature (Lond) 2002;415:530-6.
42. Bailly M, Ichetovkin I, Grant W, et al. The F-actin side binding activity of the Arp2/3 complex is essential for actin nucleation and lamellipod extension. Curr Biol 2001;11:620-5.
43. Chan AY, Bailly M, Zebda N, Segall JE, Condeelis JS. Role of cofilin in epidermal growth factor-stimulated actin polymerization and lamellipod protrusion. J Cell Biol 2000;148:531-42.
44. Ghosh M, Song X, Mouneimne G, Sidani M, Lawrence DS, Condeelis JS. Cofilin promotes actin polymerization and defines the direction of cell motility. Science (Wash DC) 2004;304:743-6.
45. Mouneimne G, Soon L, DesMarais V, et al. Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation. J Cell Biology 2004;166:697-708.
46. Devreotes P, Janetopoulos C. Eukaryotic chemotaxis: distinctions between directional sensing and polarization. J Biol Chem 2003;278:20445-8.
47. Carlier MF. Control of actin dynamics. Curr Opin Cell Biol 1998;10:45-51.
48. Davila M, Frost AR, Grizzle WE, Chakrabarti R. LIM kinase 1 is essential for the invasive growth of prostate epithelial cells: implications in prostate cancer. J Biol Chem 2003;278:36868-75.
49. Yoshioka K, Foletta V, Bernard O, Itoh K. A role for LIM kinase in cancer invasion. Proc Natl Acad Sci USA 2003;100:7247-52.
50. Zebda N, Bernard O, Bailly M, Welti S, Lawrence DS, Condeelis JS. Phosphorylation of ADF/cofilin abolishes EGF-induced actin nucleation at the leading edge and subsequent lamellipod extension. J Cell Biol 2000;151:1119-28.
51. Sahai E, Olson MF, Marshall CJ. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J 2001;20:755-66.
52. Kamai T, Tsujii T, Arai K, et al. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 2003;9:2632-41.
53. Di Modugno F, Bronzi G, Scanlan MJ, et al. Human Mena protein, a serex-defined antigen overexpressed in breast cancer eliciting both humoral and CD8+ T-cell immune response. Int J Cancer 2004;109:909-18.
54. Otsubo T, Iwaya K, Mukai Y, et al. Involvement of Arp2/3 complex in the process of colorectal carcinogenesis. Mod Pathol 2004;17:461-7.
55. Parent CA, Devreotes PN. A cell's sense of direction. Science (Wash DC) 1999;284:765-70.
56. Iijima M, Huang YE, Devreotes P. Temporal and spatial regulation of chemotaxis. Dev Cell 2002;3:469-78.
57. Yaniv K, Yisraeli JK. The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis. Gene 2002;287:49-54.
58. Tessier CR, Doyle GA, Clark BA, Pitot HC, Ross J. Mammary tumor induction in transgenic mice expressing an RNA-binding protein. Cancer Res 2004;64:209-14.
59. Herrick DJ, Ross J. The half-life of c-myc mRNA in growing and serum-stimulated cells: influence of the coding and 3′ untranslated regions and role of ribosome translocation. Mol Cell Biol 1994;14:2119-28.